Medicus Pharma Ltd (NASDAQ:MDCX) Stock Now Rated “Hold” by Wall Street Analysts

Shares of Medicus Pharma Ltd (NASDAQ:MDCX) have been assigned a consensus recommendation of “Hold” from the five brokerages that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $450.00.

MDCX has been the topic of a number of research reports. Wall Street Zen lowered shares of Medicus Pharma from a “sell” rating to a “strong sell” rating in a research report on Sunday. Weiss Ratings raised Medicus Pharma from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, October 30th. Brookline Capital Markets lowered Medicus Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Alliance Global Partners reiterated a “buy” rating on shares of Medicus Pharma in a research report on Monday, September 14th.

Institutional Trading of Medicus Pharma

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Interchange Capital Partners LLC raised its holdings in Medicus Pharma by 33.9% during the 3rd quarter. Interchange Capital Partners LLC now owns 2,124,910 shares of the company’s stock worth $343,000 after purchasing an additional 538,039 shares during the last quarter. Private Advisor Group LLC boosted its stake in shares of Medicus Pharma by 36.8% in the 1st quarter. Private Advisor Group LLC now owns 240,055 shares of the company’s stock valued at $110,000 after purchasing an additional 64,560 shares during the last quarter. Finally, Sterling Investment Advisors Ltd. bought a new position in shares of Medicus Pharma in the 2nd quarter valued at about $45,000.

Medicus Pharma Trading Down 7.2%

NASDAQ MDCX traded down $0.13 on Wednesday, hitting $1.70. 39,550 shares of the company were exchanged, compared to its average volume of 82,497. The firm has a 50 day moving average of $5.69 and a two-hundred day moving average of $21.07. The company has a market cap of $2.14 million, a P/E ratio of -0.02 and a beta of 0.80. Medicus Pharma has a 1-year low of $1.68 and a 1-year high of $127.50.

Medicus Pharma (NASDAQ:MDCX) last posted its quarterly earnings data on Friday, November 6th. The company reported ($11.64) earnings per share for the quarter, missing the consensus estimate of ($8.50) by ($3.14). Research analysts anticipate that Medicus Pharma will post -33.50 EPS for the current fiscal year.

About Medicus Pharma

Medicus Pharma Ltd. (NASDAQ:MDCX) is a life sciences company focused on acquiring, developing and commercializing pharmaceutical and medical products. The company seeks to identify therapies and healthcare technologies with potential for commercialization and works to advance them through regulatory, clinical and market-development processes. Medicus Pharma’s activities are centered on specialty healthcare markets, including pharmaceutical and medical products designed to address unmet patient and provider needs.